What are the effects of long-term Flutamide use on a woman with Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Effects of Long-Term Flutamide Use on Women with PCOS

The effects of long-term Flutamide use on women with Polycystic Ovary Syndrome (PCOS) can be understood through various studies that have investigated its impact on different aspects of the syndrome.

  • Lipid Profile: Studies have shown that Flutamide can improve the lipid profile in women with PCOS. For example, a study published in 1998 found that treatment with Flutamide was associated with a significant decrease in the LDL/HDL ratio, total cholesterol, LDL, and triglycerides 1. Another study published in 2004 found that Flutamide treatment decreased visceral fat, androstenedione, DHEA-S, total and low-density lipoprotein (LDL) cholesterol, and improved hirsutism 2.
  • Ovulatory Function: Flutamide has been shown to have a positive effect on ovulatory function in women with PCOS. A study published in 2013 found that Flutamide therapy increased the percentage of cycles that were ovulatory and regularized the menstrual profile in PCOS patients 3.
  • Hormonal Parameters: Flutamide has been found to have various effects on hormonal parameters in women with PCOS. For example, a study published in 2000 found that Flutamide restored sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone 4. Another study published in 2023 found that low-dose Flutamide reduced serum luteinizing hormone and androgen levels, and attenuated lipid accumulation in newly formed adipocytes derived from subcutaneous abdominal adipose stem cells 5.
  • Abdominal Adipogenic Function: Flutamide has been found to reduce abdominal fat deposition and attenuate accelerated lipid accumulation in newly formed adipocytes derived from subcutaneous abdominal adipose stem cells in normal-weight women with PCOS 5.

Key Findings

  • Flutamide improves lipid profile in women with PCOS 1, 2
  • Flutamide increases ovulatory function and regularizes menstrual profile in PCOS patients 3
  • Flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone 4
  • Flutamide reduces abdominal fat deposition and attenuates lipid accumulation in newly formed adipocytes derived from subcutaneous abdominal adipose stem cells 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.